SCHEMBL6073833

SCHEMBL6073833

CCOc1ccc2c(c1)CCC(=O)N2C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 10/20 0.52
CYP11B1 P15538 9/20 0.52
CYP1A2 P05177 2/20 0.52
TRIM24 O15164 2/20 0.52
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
LMNA P02545 1/20 0.50
CYP19A1 P11511 2/20 0.49
CYP3A4 P08684 1/20 0.49
CDC25A P30304 1/20 0.48
CDC25B P30305 1/20 0.48
CDC25C P30307 1/20 0.48
DUSP3 P51452 1/20 0.48
CYP17A1 P05093 1/20 0.46
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
THRB P10828 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25921025 0.88 CYP11B1 (0.50) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL25921019 0.84 TRIM24 (0.49) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL11071120 0.84 TRIM24 (0.49) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL26029521 0.84 TRIM24 (0.57) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL25317371 0.83 TRIM24 (0.48) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL7598773 0.83 GABRG2 (0.50) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL1239759 0.83 TRIM24 (0.48) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL30548213 0.83 TRIM24 (0.48) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL6073478 0.83 TRIM24 (0.64) CYP11B2CYP11B1CYP1A2TRIM24GABRG2
SCHEMBL11768561 0.82 LMNA (0.48) CYP11B2CYP11B1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 CYP11B2 3109/4885CYP11B1 2904/4885CYP1A2 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.